These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 14757169)
1. Inhibition of glycogen breakdown by imino sugars in vitro and in vivo. Andersson U; Reinkensmeier G; Butters TD; Dwek RA; Platt FM Biochem Pharmacol; 2004 Feb; 67(4):697-705. PubMed ID: 14757169 [TBL] [Abstract][Full Text] [Related]
2. N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. Andersson U; Butters TD; Dwek RA; Platt FM Biochem Pharmacol; 2000 Apr; 59(7):821-9. PubMed ID: 10718340 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of α-glucosidase activity by N-deoxynojirimycin analogs in several insect phloem sap feeders. Ya'kobovitz MK; Butters TD; Cohen E Insect Sci; 2016 Feb; 23(1):59-67. PubMed ID: 25900765 [TBL] [Abstract][Full Text] [Related]
4. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544 [TBL] [Abstract][Full Text] [Related]
6. Strain-specific antiviral activity of iminosugars against human influenza A viruses. Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974 [TBL] [Abstract][Full Text] [Related]
7. Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Andersson U; Smith D; Jeyakumar M; Butters TD; Borja MC; Dwek RA; Platt FM Neurobiol Dis; 2004 Aug; 16(3):506-15. PubMed ID: 15262262 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of alpha-glucosidases I and II increases the cell surface expression of functional class A macrophage scavenger receptor (SR-A) by extending its half-life. Tian G; Wilcockson D; Perry VH; Rudd PM; Dwek RA; Platt FM; Platt N J Biol Chem; 2004 Sep; 279(38):39303-9. PubMed ID: 15234963 [TBL] [Abstract][Full Text] [Related]
9. Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice. Denny CA; Heinecke KA; Kim YP; Baek RC; Loh KS; Butters TD; Bronson RT; Platt FM; Seyfried TN J Neurochem; 2010 Jun; 113(6):1525-35. PubMed ID: 20374428 [TBL] [Abstract][Full Text] [Related]
10. Alkylated imino sugars, reversible male infertility-inducing agents, do not affect the genetic integrity of male mouse germ cells during short-term treatment despite induction of sperm deformities. Suganuma R; Walden CM; Butters TD; Platt FM; Dwek RA; Yanagimachi R; van der Spoel AC Biol Reprod; 2005 Apr; 72(4):805-13. PubMed ID: 15576825 [TBL] [Abstract][Full Text] [Related]
11. Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. van der Spoel AC; Jeyakumar M; Butters TD; Charlton HM; Moore HD; Dwek RA; Platt FM Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17173-8. PubMed ID: 12477936 [TBL] [Abstract][Full Text] [Related]
12. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations. Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881 [TBL] [Abstract][Full Text] [Related]
13. Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120. Karlsson GB; Butters TD; Dwek RA; Platt FM J Biol Chem; 1993 Jan; 268(1):570-6. PubMed ID: 8416962 [TBL] [Abstract][Full Text] [Related]
14. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880 [TBL] [Abstract][Full Text] [Related]
15. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Priestman DA; van der Spoel AC; Butters TD; Dwek RA; Platt FM Diabetes Obes Metab; 2008 Feb; 10(2):159-66. PubMed ID: 18190430 [TBL] [Abstract][Full Text] [Related]
16. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. Platt FM; Neises GR; Dwek RA; Butters TD J Biol Chem; 1994 Mar; 269(11):8362-5. PubMed ID: 8132559 [TBL] [Abstract][Full Text] [Related]
17. Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ. Mehta A; Ouzounov S; Jordan R; Simsek E; Lu X; Moriarty RM; Jacob G; Dwek RA; Block TM Antivir Chem Chemother; 2002 Sep; 13(5):299-304. PubMed ID: 12630678 [TBL] [Abstract][Full Text] [Related]
18. Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease. Brumshtein B; Greenblatt HM; Butters TD; Shaaltiel Y; Aviezer D; Silman I; Futerman AH; Sussman JL J Biol Chem; 2007 Sep; 282(39):29052-29058. PubMed ID: 17666401 [TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation. van der Spoel AC; Mott R; Platt FM Pharmacogenomics; 2008 Jun; 9(6):717-31. PubMed ID: 18518850 [TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. Kuriyama C; Kamiyama O; Ikeda K; Sanae F; Kato A; Adachi I; Imahori T; Takahata H; Okamoto T; Asano N Bioorg Med Chem; 2008 Aug; 16(15):7330-6. PubMed ID: 18595718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]